Maryann Cimino Email

Director Investor Relations & Corporate Communications . IO Biotech

Current Roles

Employees:
112
Revenue:
$7.4M
About
IO Biotech is a clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer. Our pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of T cells that are specific for immune inhibitory molecules. IO Biotech has achieved a proven track record of progressing compounds to the clinic, and has two lead immune modulating anti-cancer therapies targeting IDO and PD-L1 in clinical development and several compounds finalizing preclinical phase. IO Biotech has an experienced management team within immuno-oncology fields and a world-class advisory board.
IO Biotech Address
430 E 29th St
Copenhagen, null
IO Biotech Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.